Biogenic Amine Transporters

Doctor Randy Blakely introduces biogenic amines transporters, which remove biogenic amines such as serotonin, dopamine, and norepinephrine from extracellular space, keeping the path clear for the next pulse of neurotransmitter.

Biogenic amine transporters are membrane proteins that assist in the ability of these small molecules called biogenic amines, like serotonin, dopamine, and norepinephrine, to act at brain synapses. When these molecules are released, they need to have a finite duration of action, and their action should not spread very far beyond an initial synapse or a small set of synapses, and these biogenic amine transporters are proteins that remove the neurotransmitters from the extracellular space and keep the path clear for the next arriving pulse of neurotransmitter.

brain synapses, dopamine and norepinephrine, finite duration, membrane proteins, extracellular space, amines, neurotransmitters, synapse, biogenic amine, randy, blakely

Related Content

2274. Biogenic Amine Transporters

Professor Randy Blakely explains that biogenic amines include transmitters like serotonin, dopamine, and norepinephrine. Transporters assist these amines at synapses.

  • ID: 2274
  • Source: G2C

2275. Polymorphisms,Transporter Proteins, and Targeted Therapy

Professor Randy Blakely discusses the impact of gene variation (polymorphisms) on transporter proteins. Impact can be very subtle and is linked to regulatory processes.

  • ID: 2275
  • Source: G2C

1392. Biochemistry of Depression

Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.

  • ID: 1392
  • Source: G2C

2399. New Perspectives on Neurotransmitter Malfunction

Doctor Randy Blakely speculates that the traditional view that drugs though to increase serotonin and dopamine levels in the brain may work by preventing a backward-running state.

  • ID: 2399
  • Source: G2C

2397. Dopamine Transporter Networks

Doctor Randy Blakely discusses the potential role of the dopamine transporter (DAT) as one element of a complex protein network in ADHD and bipolar disorder.

  • ID: 2397
  • Source: G2C

2393. Treating ADHD with Amphetamine

Doctor Randy Blakely describes an intriguing hypothesis for why amphetamine may be effective in treating some individuals with ADHD.

  • ID: 2393
  • Source: G2C

2398. Dopamine and Serotonin Systems and Disorder

Doctor Randy Blakely discusses the role of the dopamine and serotonin systems in a number of clinical disorders.

  • ID: 2398
  • Source: G2C

2371. Autism - A Synapse-Opathy

Doctor Gul Dolen defines synapse-opathies as disease where the synapse is the part of the brain that is disrupted. Fragile X and autism are examples.

  • ID: 2371
  • Source: G2C

1900. UNC18/A0238

The UNC18 protein, also known as A0238, is involved in the regulation of vesicle release from the synaptic membrane and is essential to neurotransmission.

  • ID: 1900
  • Source: G2C

814. Dopamine Hypothesis of Schizophrenia

Professor Jeffrey Lieberman discusses the dopamine hypothesis, the predominant neurochemical theory of schizophrenia.

  • ID: 814
  • Source: G2C